IL2 and melanoma: In this study, we in vitro generated IL-2 and IL-7 effectors derived from congenic mice and assessed vulnerability of IL-2 and IL-7 effectors to Treg cells in vitro, and then in vivo in a mouse model of subcutaneous tumor, B16 melanoma that provides an in vivo Treg-cell-enriched environment.